AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
70 hedge funds and large institutions have $59.9M invested in AVEO Pharmaceuticals, Inc. in 2013 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 23 increasing their positions, 28 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
52% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 21
Holders
70
Holding in Top 10
2
Calls
$6K
Puts
$6K
Top Buyers
| 1 | +$5.49M | |
| 2 | +$2.95M | |
| 3 | +$2.74M | |
| 4 |
VAM
Visium Asset Management
New York
|
+$736K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$483K |
Top Sellers
| 1 | -$3.81M | |
| 2 | -$1.53M | |
| 3 | -$1.18M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.15M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.14M |